New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
09:31 EDTNWBONorthwest Biotherapeutics price target raised to $15.10 at Summer Street
Summer Street raised its price target for Northwest Biotherapeutics shares to $15.10 from $10.33 after the company announced that Germany has approved its glioblastoma multiforme vaccine for an early access program. The firm views the news as a "very strong endorsement" from the German government and reiterates a Buy rating on Northwest.
News For NWBO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 16, 2015
17:28 EDTNWBONorthwest Biotherapeutics files to delay Form 10-K
The company requires additional time to complete its year end procedures. Those procedures could not be completed without incurring undue hardship and expense. The company undertakes the responsibility to file such annual report no later than fifteen days after its original date.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use